Puravankara Limited schedules an analyst/investor meet on May 19, 2026, to discuss Q4 and FY26 audited financial results.
The meeting will feature key management including MD Ashish Puravankara, CEOs, and the CFO, with dial-in access provided.
The company explicitly states that no unpublished price sensitive information (UPSI) will be shared during the discussion.
The event is a regulatory disclosure under SEBI LODR Regulations, with an invitation and dial-in details attached.